gilteritinib

Italy

Drugs containing this active substance

  • XOSPATA

    It is used for the treatment of adults with acute myeloid leukemia (AML), a type of cancer that affects white blood cells, specifically when the disease is associated with a FLT3 gene mutation and has recurred or has not improved after other treatments.

    Form: tablets, film-coated

    Active substance Dosage
    gilteritinib -

    ATC: L01EX13

    Manufacturer: ASTELLAS PHARMA EUROPE B.V.